FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and can be used to create a model of treating aseptic aminobisphosphonate osteonecrosis of lower jaw when examining recovery processes in mandibular bones. Method of treating aseptic bisphosphonate osteonecrosis of lower jaw in laboratory white rats experimentally involves administering pamidronic acid in dose of 60 to 150 mg/kg once day for 3 months to create a lower jaw osteonecrosis model, followed by intragastric daily administration of Trilon B aqueous solution in dose of 250 mg/kg for 1 month.
EFFECT: invention provides the possibility to restore normal processes of lower jaw bone remodeling and leads to involution processes myelofibrotic and osteonecrotic changes.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MODELING ASEPTIC AMINOBISPHOSPHONATE OSTEONECROSIS OF LOWER JAWS IN LABORATORY WHITE RATS | 2016 |
|
RU2653627C1 |
| METHOD OF MODELING ZERO STAGE OF OSTEONECROSIS OF THE LOWER JAW OF DRUGS ADDICTS | 2018 |
|
RU2680095C1 |
| METHOD OF CONSERVATIVE TREATMENT OF BISPHOSPHONATE OSTEONECROSIS OF JAWS | 2017 |
|
RU2691075C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF BIPHOSPHONATE OSTEONEKROSIS OF THE LOWER JAW IN THERAPY WITH ZOLENDRONIC ACID | 2021 |
|
RU2765638C1 |
| METHOD FOR CREATING SEGMENTAL OSTEONECROSIS MODEL OF CONDYLE FORMING ANIMAL KNEE JOINT | 2004 |
|
RU2269824C2 |
| METHOD OF TREATING ASEPTIC NECROSIS OF FEMORAL HEAD USING OSTEOTROPIC AND VASCULAR THERAPY IN COMBINATION WITH TUNNELLING OF LESIONS AND INTRODUCTION OF AUTOLOGOUS BONE MARROW CONCENTRATE | 2023 |
|
RU2816790C1 |
| METHOD FOR ACCELERATING REPARATIVE OSTEOGENESIS IN BISPHOSPHONATE OSTEONECROSIS | 2020 |
|
RU2745584C1 |
| METHOD FOR TOPOGRAPHY OF MANDIBULAR AREAS FOR DENSITOMETRY ON POSITRON-EMISSION TOMOGRAPHY SCANS | 2021 |
|
RU2779366C1 |
| METHOD FOR TREATING COMPLICATED BIOPHOSPHONATE OSTEOMYELITIS OF JAW BONES | 2019 |
|
RU2700497C1 |
| METHOD FOR LEGG-CALVE-PERTHES DISEASE SIMULATION | 2016 |
|
RU2626567C1 |
